Urorec® (silodosin) Capsules
From 1 July 2020, UROREC (silodosin) is available on the Repatriation Schedule of Pharmaceutical Benefits (RPBS).
For information on the RPBS listing click here
For additional safety and other information, please see Product information
For additional consumer information, please see Consumer Medicine Information
The following digital patient resources are available: